ASPIRIN IS PROVEN TO REDUCE THE RISK OF RECURRENT MI* AND ISCHEMIC STROKE

Studies show that aspirin can reduce the risk of:

31% decline icon

Recurrent myocardial infarction by

22% decline icon

Recurrent ischemic stroke by

Discontinuing an aspirin regimen can increase the risk of:

63% growth icon

Recurrent myocardial infarction by

40% growth icon

Recurrent ischemic stroke by

Aspirin plays a critical role in dual antiplatelet therapy.
For maximum efficacy, remind patients to continue taking aspirin with their Rx antiplatelet.

Aspirin has a well-established safety profile when used as directed.

less than 1% icon

OF PATIENTS TAKING ASPIRIN FOR SECONDARY PREVENTION experienced a non-life-threatening GI bleed4†

1.5 icon

DEATHS CAN BE PREVENTED
for every nonfatal GI bleed caused by aspirin use4†

*Nonfatal MI.
†In a meta-analysis of 6300 patients.

References: 1. Antithrombotic Trialists' (ATT) Collaboration. Lancet. 2009;373(9678):1849-1860. 2. Garcia Rodríguez LA, Cea-Soriano L, Martín-Merino E, Johansson S. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ. 2011;343:d4094. 3. Garcia Rodríguez LA, Cea Soriano L, Hill C, Johansson S. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology. 2011;76(8):740-746. 4. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002;16(19):2197-2202.